Skip to main content
. 2023 Apr 14;14(4):271. doi: 10.1038/s41419-023-05803-2

Fig. 6. Schematic diagram of CYP1B1 inducing ACSL4 degradation and inhibiting ferroptosis.

Fig. 6

Briefly, CYP1B1 metabolizes AA to 20-HETE to activate the PKC pathway, thereby increasing FBXO10 expression, which promotes ACSL4 degradation and leads to tumor cell resistance to ferroptosis. The lower right side shows the chemical structures of AA and 20-HETE.